Table 3.
Chain End vs. Living Donor HR (95% CI) |
p-value | Chain End vs. Deceased Donor HR (95% CI) |
p-value | |
---|---|---|---|---|
Death-Censored Graft Failure | ||||
Recipient Adjusted1 | 1.80 (1.32, 2.46) | <0.001 | 0.93 (0.69, 1.26) | 0.6 |
Recipient + Donor Adjusted2 | 2.27 (1.37, 3.77) | <0.01 | 1.17 (0.73, 1.87) | 0.5 |
Full Parsimonious Adjusted3 | 2.31 (1.38, 3.85) | <0.01 | 1.19 (0.74, 1.90) | 0.5 |
Mortality | ||||
Recipient Adjusted | 1.48 (1.12, 1.97) | <0.01 | 0.65 (0.49, 0.86) | <0.01 |
Recipient + Donor Adjusted | 1.38 (0.92, 2.09) | 0.1 | 0.61 (0.43, 0.87) | <0.01 |
Full Parsimonious Adjusted | 1.39 (0.91, 2.13) | 0.1 | 0.62 (0.43, 0.90) | 0.01 |
Adjusted for recipient factors: female sex, African American race, Hispanic ethnicity, age, BMI>30 kg/m2, diabetes, hypertension, history of transplant, college education, year of transplant, public insurance status, HCV, preemptive transplant, eGFR, and type of induction.
Adjusted for recipient factors above and donor factors: BMI>30 kg/m2, female sex, African-American race, Hispanic ethnicity, age, eGFR, and LKDPI/KDPI.
Adjusted for recipient sex, recipient African-American race, recipient age, recipient BMI>30 kg/m2, donor BMI>30 kg/m2, recipient diabetes, history of previous transplant, donor sex, donor Hispanic ethnicity, year of transplant, recipient public insurance status, recipient HCV, donor age, preemptive transplant, recipient eGFR, type of induction, number of HLA mismatches, and LKDPI/KDPI.